Diagnostic and Interventional Cardiology

News | Cardiac Imaging

Artificial Intelligence Speeds Up Heart Scans, Leading to Efficiency and Improving Outcomes

July 12, 2024 — Researchers have developed a groundbreaking method for analyzing heart MRI scans with the help of ...

July 12, 2024

First implant of Amvia Sky in Canada performed at the Centre Hospitalier de l'Université de Montréal

News | Implantable Cardiac Monitor (ICM)

Amvia Sky Launched in Canada, the World’s First Pacemaker Approved for LBBAP

July 11, 2024 — Dr. Fadi Mansour performed the first Canadian implant of BIOTRONIK’s newest pacemaker and CRT-P ...

July 11, 2024

Further expands HeartSciences extensive patent portfolio

News | Artificial Intelligence

HeartSciences Announces Allowance of U.S Patent for AI-ECG Assessment of Left Ventricular and Right Ventricular Heart Dysfunction

July 11, 2024 — Heart Test Laboratories, Inc. an artificial intelligence (AI)-powered medical technology company focused ...

July 11, 2024

Sponsored Content

ASCEND provides the tools that not only address the unique needs of each cardiovascular subspecialty and to care for patients from infancy into their golden years, they also innovates next-generation solutions and services that empower the provider community to truly transform their cardiovascular services

Feature | Information Technology

SPONSORED CONTENT: Unveiling the Future of Cardiovascular Workflow

Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...

March 21, 2024

Medical device company R3 Vascular Inc., a developer of novel, best-in-class bioresorbable scaffolds for treating peripheral arterial disease (PAD), has announced the appointment of Josh Smale as its Vice President of Global Clinical and Scientific Affairs.

News | Cardiovascular Business

R3 Vascular Appoints Josh Smale as Vice President of Global Clinical and Scientific Affairs

July 11, 2024 — Medical device company R3 Vascular Inc., developer of novel, best-in-class bioresorbable scaffolds for ...

July 11, 2024

Findings from an observational analysis of ARISE-HF trial participants, newly-published in the Journal of the American College of Cardiology, JACC, shed light on the racial and ethnic disparities in diabetic cardiomyopathy (DbCM).

News | ACC

Study Calls for Targeted Strategies for Managing Diabetic Cardiomyopathy Across Racial, Ethnic Groups

July 10, 2024 — Findings from an observational analysis of ARISE-HF trial participants, newly-published in the Journal ...

July 10, 2024

Feature | Remote Monitoring | By Stuart Long

Step Into the Cardiology Clinic of the Future: Bringing Virtual Cardiac Care Delivery and Virtual Telemetry to Life in Your Practice’s Clinical Workflows

In a room of 20 people, it’s likely that about 10 of them, or half, will presently have some form of cardiovascular ...

July 10, 2024

Sponsored Content

Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability to diagnose cardiac disease with greater accuracy and precision

Feature | Cardiac Imaging

SPONSORED CONTENT: Finding the Right Solution

Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...

March 05, 2024

News | Cardiovascular Clinical Studies

CellProthera and BioCardia Collaborate on Successful Phase II Trial of ProtheraCytes for the Treatment of Acute Myocardial Infarction

July 10, 2024 — CellProthera, a private company specializing in cell-based therapies for repairing ischemic tissues, and ...

July 10, 2024

Patent covers brilaroxazine use for treating pulmonary hypertension (PH), pulmonary arterial hypertension (PAH) in any patients including treating PH in patients with chronic obstructive pulmonary disease (COPD) or sickle cell disease (SCD)

News | Pharmaceuticals

Reviva Announces Grant of European Patent Covering Use of Brilaroxazine for the Treatment of Pulmonary Hypertension

July 10, 2024 — Reviva Pharmaceuticals Holdings, Inc., a late-stage pharmaceutical company developing therapies that ...

July 10, 2024

Keith Churchwell, M.D., FAHA, has been named new volunteer president at the American Heart Association for fiscal year 2024-2025.

News | AHA

American Heart Association Announces New 2024-2025 National Volunteer Leaders

July 9, 2024 — The American Heart Association, celebrating 100 years of lifesaving service as the world’s leading ...

July 09, 2024

Sponsored Content

Blog

BLOG: Combining Local Impedance with Contact Force to Perform RF Ablation

When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...

December 11, 2023

Counties tend to be more rural and socioeconomically disadvantaged

News | Cardiovascular Business

Almost Half of US Counties Have No Cardiologists Despite Higher Prevalence of CV Risk Factors, Mortality

July 9, 2024 — Disparities in cardiovascular disease outcomes between urban and rural areas continue to widen, yet ...

July 09, 2024

The clinical trial is expected to support the future submission to the FDA for the commercialization of the LIBERTY Endovascular Robotic Surgical System

News | Cardiovascular Clinical Studies

Microbot Medical Enrolled the First Patient in its Pivotal Human Clinical Trial

July 9, 2024 — Microbot Medical Inc. announced the completion of the first procedure in a patient utilizing its LIBERTY ...

July 09, 2024

News | Atrial Fibrillation

Pulsed Field Ablation Procedures Found Safe and Effective for Atrial Fibrillation Patients

July 8, 2024 — Pulsed field ablation (PFA) is safe for treating patients with common types of atrial fibrillation (AF) ...

July 08, 2024

Sponsored Content

Case Study | Hemodynamic Monitoring Systems

TECH BRIEF — Integrated Hemodynamic Monitoring System Helps Improve Lab Performance, Efficiency

Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...

November 14, 2023

News | Structural Heart

Webinar on Optimizing Structural Heart Workflows to Take Place Next Week

On July 16, Diagnostic and Interventional Cardiology will present a webinar on "Maximizing Structural Heart Workflows ...

July 08, 2024

During the American Heart Association Basic Cardiovascular Sciences (BCVS) Scientific Sessions 2024 taking place in Chicago this week, two new, basic research studies in rodents (mice and rats) analyzed the impacts that alcohol may have on the heart.

News | AHA

New Research on Alcohol’s Impact on the Heart at American Heart Association Basic Cardiovascular Sciences Scientific Sessions 2024

July 24, 2024 — During the American Heart Association Basic Cardiovascular Sciences Scientific Sessions 2024, BCVS ...

July 05, 2024

Feature | Cardiovascular Business

Happy 4th from the DAIC team

The DAIC team wishes you a safe and happy 4th of July!

July 04, 2024